Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CJ-15314 Phosphate in Healthy Male Subjects

NCT04297865 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: A dose as CJ-15314
DRUG: B dose as CJ-15314
DRUG: C dose as CJ-15314
DRUG: D dose as CJ-15314
DRUG: E dose as CJ-15314
DRUG: F dose as CJ-15314
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo
DRUG: Placebo

Sponsor

HK inno.N Corporation